Related references
Note: Only part of the references are listed.Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2′-deoxyguanosine in patients with multiple sclerosis
Negin Bodaghi Khajenobar et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Age-related magnetic susceptibility changes in deep grey matter and cerebral cortex of normal young and middle-aged adults depicted by whole brain analysis
Romana Burgetova et al.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2021)
Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder
A. Uzawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
Katariina Hanninen et al.
FRONTIERS IN NEUROLOGY (2020)
Oxidative Stress Marker Aberrations in Multiple Sclerosis: A Meta-Analysis Study
Shu-Yao Zhang et al.
FRONTIERS IN NEUROSCIENCE (2020)
Monitoring the Redox Status in Multiple Sclerosis
Masaru Tanaka et al.
BIOMEDICINES (2020)
Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability
Mariacristina Siotto et al.
FRONTIERS IN NEUROSCIENCE (2019)
Measurement of Neutrophil Gelatinase-Associated Lipocalin Concentration in Canine Cerebrospinal Fluid and Serum and Its Involvement in Neuroinflammation
Nina Meyerhoff et al.
FRONTIERS IN VETERINARY SCIENCE (2019)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Redox Balance, Antioxidant Defense, and Oxidative Damage in the Hypothalamus and Cerebral Cortex of Rats with High Fat Diet-Induced Insulin Resistance
Mateusz Maciejczyk et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation
David Voigt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
MRI evaluation of thalamic volume differentiates MS from common mimics
Andrew J. Solomon et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis
A. Burgetova et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
MRICloud: Delivering High-Throughput MRI Neuroinformatics as Cloud-Based Software as a Service
Susumu Mori et al.
COMPUTING IN SCIENCE & ENGINEERING (2016)
Multiple Roles of Peroxiredoxins in Inflammation
Bernard Knoops et al.
MOLECULES AND CELLS (2016)
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Regulated necrosis: disease relevance and therapeutic opportunities
Marcus Conrad et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
Bozena Adamczyk et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
Faiez Al Nimer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS
Magda A. Lam et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study
M. Khalil et al.
NEUROLOGY (2015)
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
Elzbieta Miller et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
Antonio Ayala et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter by Using Susceptibility-based MR Imaging
David A. Rudko et al.
RADIOLOGY (2014)
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis
Fozia Mir et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Peripheral oxidative stress in relapsing-remitting multiple sclerosis
Inmaculada Tasset et al.
CLINICAL BIOCHEMISTRY (2012)
8OHdG as a marker for Huntington disease progression
Jeffrey D. Long et al.
NEUROBIOLOGY OF DISEASE (2012)
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
Paul Schmidt et al.
NEUROIMAGE (2012)
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
Christian Langkammer et al.
NEUROIMAGE (2012)
Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
Cynthia A. Massaad et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Oxidative damage in multiple sclerosis lesions
Lukas Haider et al.
BRAIN (2011)
Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T-2 Relaxometry
A. Burgetova et al.
EUROPEAN NEUROLOGY (2010)
8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases
K. Gmitterova et al.
NEURODEGENERATIVE DISEASES (2009)
Share Paper
